Aberdeen Group’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $778K | Buy |
5,127
+1,586
| +45% | +$241K | ﹤0.01% | 845 |
|
|
2025
Q1 | $528K | Sell |
3,541
-14,276
| -80% | -$2.13M | ﹤0.01% | 870 |
|
|
2024
Q4 | $3.29M | Sell |
17,817
-1,027
| -5% | -$190K | 0.01% | 708 |
|
|
2024
Q3 | $3.71M | Sell |
18,844
-106,170
| -85% | -$20.9M | 0.01% | 695 |
|
|
2024
Q2 | $25.8M | Buy |
125,014
+13,011
| +12% | +$2.69M | 0.05% | 322 |
|
|
2024
Q1 | $30.3M | Sell |
112,003
-9,804
| -8% | -$2.66M | 0.06% | 306 |
|
|
2023
Q4 | $28.8M | Buy |
121,807
+109,275
| +872% | +$25.8M | 0.06% | 299 |
|
|
2023
Q3 | $2.46M | Sell |
12,532
-404
| -3% | -$79.2K | 0.01% | 663 |
|
|
2023
Q2 | $2.72M | Sell |
12,936
-150
| -1% | -$31.5K | 0.01% | 680 |
|
|
2023
Q1 | $2.64M | Sell |
13,086
-10
| -0.1% | -$2.02K | 0.01% | 691 |
|
|
2022
Q4 | $2.85M | Buy |
13,096
+978
| +8% | +$213K | 0.01% | 654 |
|
|
2022
Q3 | $2.39M | Buy |
12,118
+102
| +0.8% | +$20.1K | 0.01% | 678 |
|
|
2022
Q2 | $2.6M | Sell |
12,016
-425
| -3% | -$91.8K | 0.01% | 675 |
|
|
2022
Q1 | $3.59M | Sell |
12,441
-2,348
| -16% | -$678K | 0.01% | 655 |
|
|
2021
Q4 | $5.57M | Sell |
14,789
-880
| -6% | -$332K | 0.01% | 618 |
|
|
2021
Q3 | $6.59M | Buy |
15,669
+2,544
| +19% | +$1.07M | 0.01% | 598 |
|
|
2021
Q2 | $4.86M | Buy |
+13,125
| New | +$4.86M | 0.01% | 652 |
|